CHLA/USC Cell Therapy Program Seminar Series - Jordan Gauthier: Advancing CAR T-cell therapy for high-risk B-NHL
Thursday, October 6, 2022 12pm to 1pm
Thursday, October 6, 2022 12pm to 1pm
About this Event
USC/CHLA Cell Therapy Program Seminar Series invites you to learn more about
Second-line (2L) standard-of-care (SOC) for large B-cell lymphoma (LBCL)
CD19 CAR-T for relapsed/refractory (R/R) LBCL (>2L)
Impact of the CD19 CAR product on outcomes of R/R LBCL
CD19 CAR-T versus SOC for 2L high-risk LBCL
This program is open to all eligible individuals. USC operates all of its programs and activities consistent with the university’s Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation or any other prohibited factor.
1 person is interested in this event
Please register to join the seminar
https://usc.zoom.us/meeting/register/tJckfuuvqzIpHtDz30KDsDat3_Bsoanx4sLO
User Activity
No recent activity